PresseMitteilungen CategoriesNewBiotechCategory / Pharmaceuticals & Biotech / Biotech Marina Biotech Receives Three Notices of Allowances From the USPTO and an Intent to Grant Notice From the European Patent Office BOTHELL, WA: Expands Patent Protection for SMARTICLES(R) and DiLA2(TM) Delivery Platforms ... Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2012 Financial Results SOUTH SAN FRANCISCO, CA: ... Genetic Technologies Executes Settlement and License Agreement With GeneSeek Inc. MELBOURNE, AUSTRALIA: ... ProMetic Reports Highlights of its 2012 Annual and Special Meeting of Shareholders LAVAL, QUEBEC, CANADA: ... Dynavax Prices Public Offering of Common Stock BERKELEY, CA: ... Prana Chief Scientific Advisor to Give Plenary Lecture at Alzheimer's Symposium in Stockholm Featuring New Targets and Drugs MELBOURNE, AUSTRALIA: Dr. Rudy Tanzi to Discuss PBT2 Trial on Thursday, May 10 ... Thallion and LFB Report Positive Top-Line Results from the Phase II SHIGATEC Trial at 'VTEC 2012' MONTREAL, CANADA and LES ULIS, FRANCE: ... Cornerstone Therapeutics to Host First Quarter 2012 Conference Call CARY, NC: ... The Medicines Company to Participate in Bank of America Merrill Lynch 2012 Healthcare Conference PARSIPPANY, NJ: ... Medivation Reports First Quarter Financial Results and Provides Corporate Update SAN FRANCISCO, CA: Conference Call Today at 4:30 p.m. Eastern Time ... Dynavax Announces Proposed Public Offering of Common Stock BERKELEY, CA: ... Dynavax Embarks on Transition to Commercialization BERKELEY, CA: ... Cytovance(R) Biologics Names Martin LeBlanc to Board of Directors OKLAHOMA CITY, OK: ... Novo Energies Corporation Announces New Name Change to Immunovative, Inc. and New Trading Symbol "IMUN" NEW YORK, NY: ... Marina Biotech Announces Worldwide Exclusive Licensing Agreement With Monsanto BOTHELL, WA: ... Calyx Bio-Ventures Inc. Provides Corporate Update VANCOUVER, BRITISH COLUMBIA: ... TiGenix : Presenting at Key Conferences - Spring 2012 LEUVEN, BELGIUM: TiGenix to Present at Key Conferences - Spring 2012 ... ProMetic and Hematech Biotherapeutics Close $10 Million Orphan Drug License and Strategic Manufacturing Deal LAVAL, QUEBEC, CANADA and TAIPEI, TAIWAN: ... Enzon and Hisun Announce Strategic Alliance for Enzon's Customized PEGylation Linker Technology and Licensing Agreement for PEG-SN38 in China PISCATAWAY, NJ and ZHEJIANG, CHINA: ... Biolex Sells LEX System to Synthon and Initiates Sale of Locteron(R) PITTSBORO, NC: ... Page 200 von 247: 1 « .. 199 200 201 202 203 204 205 206 207 208 .. » 247